Treatment of Obsessive Compulsive Disorder in Children
Information source: Duke University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Obsessive-Compulsive Disorder
Intervention: Serotonin reuptake inhibitors management (Drug); Cognitive behavioral therapy by a psychologist (Behavioral); Instructional cognitive behavioral therapy by a psychiatrist (Behavioral)
Phase: Phase 3
Status: Completed
Sponsored by: Duke University Official(s) and/or principal investigator(s): John S March, MD MPH, Principal Investigator, Affiliation: Duke University
Summary
This study will determine whether cognitive behavioral therapy delivered by either
psychologists or psychiatrists can improve the effectiveness of serotonin reuptake inhibitor
treatment in children with obsessive compulsive disorder.
Clinical Details
Official title: Treatment of Pediatric OCD for SRI Partial Responders
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS)
Secondary outcome: Child Obsessive -Compulsive Impact Scale (COIS)Child Depression Inventory Pediatric Adverse Event Rating Scale (PAERS)
Detailed description:
The vast majority of children with obsessive compulsive disorder (OCD) are given serotonin
reuptake inhibitor (SRI) drugs as initial treatment. However, recommended doses of these
medications leave many children with clinically significant residual symptoms. Health care
experts typically recommend augmenting SRI treatment with cognitive behavioral therapy
(CBT), yet this recommendation is seldom followed. This study will contrast two CBT
augmentation strategies to continued medication management alone: CBT administered by a
psychologist and instructional CBT (I-CBT)administered by a psychiatrist in the context of
ongoing medication management.
All patients in the trial will be eligible to receive a full course of CBT by study end.
Participants in this study will be randomly assigned to receive CBT, I-CBT or continued
medication management. All participants will continue their SRI treatment for 12 weeks.
After the 12-week treatment period, participants who received I-CBT or medication
management alone and who remain symptomatic will be given CBT as will participants who are
asymptomatic but relapse within 6 months after treatment. Assessments will be conducted at
Weeks 0, 4, 8, and 12. Follow-up assessments will be conducted at 3 and 6 months
post-treatment.
Eligibility
Minimum age: 7 Years.
Maximum age: 17 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- DSM-IV Diagnosis of obsessive compulsive disorder
- CYBOCS total score greater than 16
Exclusion Criteria:
- Other primary or co-primary psychiatric disorder
- Pervasive developmental disorder or disorders, including Asperger's Syndrome
- Thought disorder
- Prior failed trial of cognitive-behavioral therapy
- Has pediatric autoimmune neuropsychiatric disorders associated with streptococcus
(PANDAS) or maintenance antibiotic for obsessive-compulsive disorder
- Mental retardation
- Pregnancy
Locations and Contacts
Duke Child and Family Study Center, Durham, North Carolina 27705, United States
University of Pennsylvania, The Center for the Treatment and Study of Anxiety, Philadelphia, Pennsylvania 19104, United States
Rhode Island Hospital, Providence, Rhode Island 02903, United States
Additional Information
Duke Program in Child Affective and Anxiety Disorders
Starting date: September 2003
Last updated: July 23, 2014
|